Regulatory

Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
When faced with legislative scrutiny, be prepared, be truthful, and don't be afraid to say 'I don't know'...
Aug 01, 2011
Pharmaceutical Executive
A number of important decisions from the Supreme Court will affect drug marketing, research, and regulation
Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
No one doubts the importance of health expenditures ? but then, euros, like dollars, don't grow on trees
Jul 01, 2011
Pharmaceutical Executive
Sponsors must handle interchangeability, exclusivity, cost and coverage hurdles to win biosimilars game
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Suggestions for testing new ways of addressing difficult issues of risk
Jun 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Successful negotiations require a willingness to take risks and an ability to adapt
Jun 01, 2011
Pharmaceutical Executive
FDA's opiod REMS implies there is still value in industry-sponsored CME
May 05, 2011
ePT--the Electronic Newsletter of Pharmaceutical Technology
A federal appeals court has lifted a ban on federal funding for embryonic stem cell research.
May 01, 2011
Pharmaceutical Executive
Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies
May 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Considering Big Pharma's trade objectives, the success of regional regulatory harmonization is not insignificant
native1_300x100
lorem ipsum